🔎 Trials Near Me

Dachaigh › Galar Alzheimer › Florida › Orlando

Sgrùdaidhean clionaigeach Galar Alzheimer ann an Orlando, FL

Tha 25 sgrùdaidhean airson Galar Alzheimer a’ lorg phàirtichean aig làraichean ann agus timcheall air Orlando (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

A’ fastadhÌre 2
  • Clinical Site, Orlando
Aoisean 55 gu 90 · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT06887192

A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

A’ fastadhÌre 2
  • K2 Medical Research, Maitland · 6 mìle air falbh
Aoisean 55 agus nas sine · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT06540833

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

A’ fastadhÌre 3
  • Local Institution - 1635, Orlando
Aoisean 55 gu 90 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT06937229

A Study of LY3439539 in Participants With Alzheimer's Disease

A’ fastadhÌre 1
  • Charter Research, Orlando
  • AdventHealth Orlando, Orlando
  • K2 Medical Research, Maitland · 6 mìle air falbh
Aoisean 50 gu 85 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT07598370

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

A’ fastadhÌre 3
  • Charter Research Orlando, Orlando
  • Nova Psychiatry, Orlando
  • Combined Research Orlando Phase I-IV LLC, Orlando
  • agus 1 a bharrachd
Aoisean 55 gu 90 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT06585787

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

A’ fastadhÌre 2
  • Charter Research - Orlando, Orlando
  • Conquest Research, Winter Park · 5 mìle air falbh
  • K2 Medical Research ORLANDO, Maitland · 6 mìle air falbh
Aoisean 55 gu 85 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07589595

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

A’ fastadhÌre 2
  • Conquest Research - Lake Nona, Orlando
Aoisean 55 gu 80 · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT06847321

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

A’ fastadhÌre 3
  • Charter Research - Winter Park/Orlando, Orlando
  • Conquest Research - Lake Nona, Orlando
  • Conquest Research, LLC, Winter Park · 5 mìle air falbh
  • agus 2 a bharrachd
Aoisean 50 gu 90 · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT07177352

A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease

A’ fastadhÌre 1/2
  • Conquest Research - Winter Park /ID# 277760, Winter Park · 5 mìle air falbh
  • K2 Medical Research - Clermont /ID# 277859, Clermont · 24 mìle air falbh
Aoisean 50 gu 90 · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT07599670

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

A’ fastadhÌre 3
  • Combined Research Orlando (CRO), Orlando
  • Local Institution - 1622, Maitland · 6 mìle air falbh
  • Local Institution - 1631, Maitland · 6 mìle air falbh
Aoisean 55 gu 90 · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT07011732

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

A’ fastadhÌre 3
  • Local Institution - 2634, Orlando
Aoisean 55 gu 90 · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT07011745

A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease

A’ fastadhÌre 3
  • K2 Medical Research, LLC, Maitland · 6 mìle air falbh
Aoisean 55 gu 80 · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT07717411

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

A’ fastadhÌre 2
  • ClinCloud, Maitland · 6 mìle air falbh
  • Local Institution - 0007, Maitland · 6 mìle air falbh
Aoisean 55 gu 90 · Gach gnè · Air ùrachadh 1 Sult 2026 · NCT06808984

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

A’ fastadhÌre 2
  • Charter Research - Orlando ( Site 1051), Orlando
  • Conquest Research LLC ( Site 1053), Winter Park · 5 mìle air falbh
  • K2 Medical Research ( Site 1047), Maitland · 6 mìle air falbh
Aoisean 50 gu 85 · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT07033494

A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

A’ fastadhÌre 1
  • K2 Medical Research, LLC, Maitland · 6 mìle air falbh
Aoisean 50 gu 85 · Gach gnè · Air ùrachadh 24 Lùna 2026 · NCT06297590

A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)

A’ fastadhÌre 1/2
  • Charter Research, LLC, Orlando
  • Headlands Horizons LLC, Orlando
Aoisean 35 gu 85 · Gach gnè · Air ùrachadh 10 Iuch 2026 · NCT05462106

Low-Dose Radiotherapy for Alzheimer's Disease

A’ fastadhÌre 1/2
  • Renaissance Institute of Precision Oncology & Radiosurgery, Winter Park · 5 mìle air falbh
Aoisean 50 agus nas sine · Gach gnè · Air ùrachadh 9 Iuch 2026 · NCT07693140

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

A’ fastadhÌre 3
  • Charter Research - Orlando, Orlando
  • Headlands Research Orlando, Orlando
  • Conquest Research, Winter Park · 5 mìle air falbh
  • agus 1 a bharrachd
Aoisean 55 agus nas sine · Gach gnè · Air ùrachadh 7 Iuch 2026 · NCT07602582

A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

A’ fastadhÌre 2
  • Conquest Research, Winter Park · 5 mìle air falbh
  • K2 Medical Research LLC, Maitland · 6 mìle air falbh
  • K2 Medical Research LLC, Maitland · 6 mìle air falbh
Aoisean 50 gu 85 · Gach gnè · Air ùrachadh 26 Ògmh 2026 · NCT07094516

A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)

A’ fastadhÌre 1Fàilte do shaor-thoilich fhallain
  • K2 Medical Research, Maitland · 6 mìle air falbh
Aoisean 45 gu 85 · Gach gnè · Air ùrachadh 4 Ògmh 2026 · NCT06657768

[18F]PI-2620 Phase 3 Histopathological Study

A’ fastadhÌre 3
  • Charter Research, Winter Park · 5 mìle air falbh
  • K2 Medical Research, Maitland · 6 mìle air falbh
Aoisean 50 agus nas sine · Gach gnè · Air ùrachadh 22 Cèit 2026 · NCT05641688

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
  • Charter Research, Orlando
  • Conquest Research, Winter Park · 5 mìle air falbh
  • K2 Medical Research, Maitland · 6 mìle air falbh
  • agus 1 a bharrachd
Aoisean 60 gu 90 · Gach gnè · Air ùrachadh 15 Gibl 2026 · NCT06584357

Open-label Extension Study in Participants With Early Alzheimer's Disease

A’ fastadhÌre 2
  • GSK Investigational Site, Maitland · 6 mìle air falbh
Aoisean 50 gu 85 · Gach gnè · Air ùrachadh 2 Gearr 2026 · NCT07105709

ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease

A’ fastadh
  • Advent Health, Orlando
Aoisean 50 gu 85 · Gach gnè · Air ùrachadh 9 Faoi 2026 · NCT03671889

University of Central Florida CereBank

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
  • University of Central Florida, Orlando
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 14 Màrt 2025 · NCT06876857

Sgrùdaidhean Galar Alzheimer ann am bailtean eile

Sgrùdaidhean eile ann an Orlando

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.